Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - l-tyrosine; l-tryptophan; l-phenylalanine; l-serine; l-proline; glycine; l-alanine; l-valine; l-isoleucine; l-leucine; l-lysine monohydrochloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium lactate; sodium chloride; l-histidine; l-threonine; l-arginine; l-methionine - solution for peritoneal dialysis - 300mg/1litre ; 270mg/1litre ; 570mg/1litre ; 510mg/1litre ; 595mg/1litre ; 510mg/1litre ; 951mg/1litre ; 1.393gram/1litre ; 850mg/1litre ; 1.02gram/1litre ; 955mg/1litre ; 184mg/1litre ; 51mg/1litre ; 4.48gram/1litre ; 5.38gram/1litre ; 714mg/1litre ; 646mg/1litre ; 1.071gram/1litre ; 850mg/1litre

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

forest pharmatech pty limited - chromium amino acid chelate, quantity: 10 mg; zinc oxide, quantity: 12.4533 mg; ferrous fumarate, quantity: 31.5457 mg; riboflavine, quantity: 25.5 mg; nicotinamide, quantity: 25.5 mg; manganese amino acid chelate, quantity: 7 mg; eleutherococcus senticosus, quantity: 5 mg (equivalent: eleutherococcus senticosus, qty 25 mg); potassium amino acid chelate, quantity: 25 mg; d-alpha-tocopherol, quantity: 51.5464 mg; ascorbic acid, quantity: 55 mg; lysine hydrochloride, quantity: 15.625 mg; pyridoxine hydrochloride, quantity: 25.5 mg; biotin, quantity: 0.025 mg; folic acid, quantity: 0.2295 mg; rutoside, quantity: 10 mg; choline bitartrate, quantity: 20.8768 mg; inositol, quantity: 10 mg; retinol palmitate, quantity: 2.5 mg; calcium hydrogen phosphate, quantity: 454.5455 mg; ubidecarenone, quantity: 0.5 mg; oryzanol, quantity: 3 mg; threonine, quantity: 3.6 mg; alanine, quantity: 6 mg; methionine, quantity: 2.7 mg; leucine, quantity: 4.69 mg; dl-phenylalanine, quantity: 4.17 mg; calcium caseinate, quantity: 9.9998 mg; ergocalciferol, quantity: 0.22 mg; heavy magnesium oxide, quantity: 45.4545 mg; hydroxocobalamin, quantity: 25 microgram; aminobenzoic acid, quantity: 10 mg - capsule, soft - excipient ingredients: vegetable oil; yellow beeswax; lecithin; gelatin; glycerol; hydrogenated vegetable oil; purified water; hydrogenated soya oil; pollen

Bandaríkin - enska - NLM (National Library of Medicine)

malin and goetz inc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 2 g in 1 ml - uses for the treatment of acne using other topical acne drugs at the same time or right after use of this product may increase dryness or irritation of the skin. if this occurs, only one drug should  be used, unless directed by a doctor

Írland - enska - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - l-tyrosine; l-tryptophan; l-phenylalanine; l-threonine; l-serine; l-proline; glycine; l-alanine; l-valine; l-methionine; l-isoleucine; l-leucine; l-lysine hydrochloride; l-histidine; l-arginine; calcium chloride; magnesium chloride; sodium (s) - lactate ; sodium chloride - solution for peritoneal dialysis - 1.1 percent - hypertonic solutions

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - sodium chloride, quantity: 5.38 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; proline, quantity: 595 mg/l; lysine hydrochloride, quantity: 955 mg/l; glycine, quantity: 510 mg/l; threonine, quantity: 646 mg/l; alanine, quantity: 951 mg/l; methionine, quantity: 850 mg/l; leucine, quantity: 1.02 g/l; arginine, quantity: 1.071 g/l; serine, quantity: 510 mg/l; valine, quantity: 1.393 g/l; isoleucine, quantity: 850 mg/l; tyrosine, quantity: 300 mg/l; phenylalanine, quantity: 570 mg/l; tryptophan, quantity: 270 mg/l; histidine, quantity: 714 mg/l; calcium chloride dihydrate, quantity: 184 mg/l; sodium lactate, quantity: 4.48 g/l - solution, dialysis - excipient ingredients: hydrochloric acid; water for injections - nutritional supplement for malnourished renal failure patients (albumin concentration lower than 35g/l) being maintained on peritoneal dialysis

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - tryptophan, quantity: 1.9 g/l; arginine, quantity: 11.3 g/l; phenylalanine, quantity: 7.9 g/l; cysteine, quantity: 0.56 g/l; tyrosine, quantity: 0.23 g/l; glycine, quantity: 7.9 g/l; threonine, quantity: 5.6 g/l; methionine, quantity: 5.6 g/l; leucine, quantity: 7.9 g/l; alanine, quantity: 16 g/l; isoleucine, quantity: 5.6 g/l; aspartic acid, quantity: 3.4 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: lysine, qty 9 g/l); serine, quantity: 4.5 g/l; histidine, quantity: 6.8 g/l; proline, quantity: 6.8 - injection, intravenous infusion - excipient ingredients: glacial acetic acid; water for injections - intravenous supply of amino acids specially to patients with highly increased requirement who are unable to receive sufficient amounts of protein enterally. vamin 18 is also indicated where there is a need to control the total amount of fluid being given to a patient.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - cysteine, quantity: 0.42 g/l; leucine, quantity: 5.9 g/l; tryptophan, quantity: 1.4 g/l; isoleucine, quantity: 4.2 g/l; alanine, quantity: 12 g/l; tyrosine, quantity: 0.17 g/l; histidine, quantity: 5.1 g/l; serine, quantity: 3.4 g/l; lysine acetate, quantity: 9.5 g/l (equivalent: lysine, qty 6.8 g/l); aspartic acid, quantity: 2.5 g/l; valine, quantity: 5.5 g/l; phenylalanine, quantity: 5.9 g/l; glycine, quantity: 5.9 g/l; methionine, quantity: 4.2 g/l; arginine, quantity: 8.4 g/l; threonine, quantity: 4.2 g - injection, intravenous infusion - excipient ingredients: water for injections; glacial acetic acid - intravenous supply of amino acids to patients with moderately increased requirement who are unable to receive sufficient amounts of protein enterally

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - cysteine, quantity: 0.42 g/l; lysine acetate, quantity: 9.5 g/l (equivalent: lysine, qty 6.8 g/l); threonine, quantity: 4.2 g/l; proline, quantity: 5.1 g/l; serine, quantity: 3.4 g/l; glutamic acid, quantity: 4.2 g/l; isoleucine, quantity: 4.2 g/l; arginine, quantity: 8.4 g/l; methionine, quantity: 4.2 g/l; phenylalanine, quantity: 5.9 g/l; glycine, quantity: 5.9 g/l; histidine, quantity: 5.1 g/l; alanine, quantity: 12 g/l; tyrosine, quantity: 0.17 g/l; tryptophan, quantity: 1.4 g/l; aspartic acid, quantity - injection, intravenous infusion - excipient ingredients: water for injections; glacial acetic acid - intravenous supply of amino acids to patients with moderately increased requirement who are unable to receive sufficient amounts of protein enterally

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - valine, quantity: 7.3 g/l; leucine, quantity: 7.9 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: lysine, qty 9 g/l); glutamic acid, quantity: 5.6 g/l; threonine, quantity: 5.6 g/l; glycine, quantity: 7.9 g/l; aspartic acid, quantity: 3.4 g/l; tyrosine, quantity: 0.23 g/l; phenylalanine, quantity: 7.9 g/l; isoleucine, quantity: 5.6 g/l; arginine, quantity: 11.3 g/l; alanine, quantity: 16 g/l; serine, quantity: 4.5 g/l; proline, quantity: 6.8 g/l; cysteine, quantity: 0.56 g/l; histidine, quantity: 6.8 g - injection, intravenous infusion - excipient ingredients: glacial acetic acid; water for injections - intravenous supply of amino acids specially to patients with highly increased requirement who are unable to receive sufficient amounts of protein enterally. vamin 18 is also indicated where there is a need to control the total amount of fluid being given to a patient.

Bandaríkin - enska - NLM (National Library of Medicine)

b. braun medical inc. - lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), alanine (unii: of5 - plenamine™ 15% is indicated as an amino acid (nitrogen) source in parenteral nutrition regimens. this use is appropriate when the enteral route is inadvisable, inadequate or not possible, as when: —   gastrointestinal absorption is impaired by obstruction, inflammatory disease or its complications, or antineoplastic therapy; —   bowel rest is needed because of gastrointestinal surgery or its complications such as ileus, fistulae or anastomotic leaks; —   tube feeding methods alone cannot provide adequate nutrition. this solution should not be used in patients in hepatic coma, severe renal failure, metabolic disorders involving impaired nitrogen utilization or hypersensitivity to one or more amino acids.